Panchsheel Organics Ltd.
BSE: PANCHSHEEL · Pharmaceuticals · sector
₹102.95BSE close 2026-10-26
Key numbers
Market cap₹136 cr
Price₹102.95
52w high / low₹154 / ₹86
P/E10.5xSector median 27.9x
P/B1.0xSector median 2.9x
Book value₹106.9
Dividend yield3.11%Sector median 0.48%
ROE7.5%Sector median 11.7%
ROCE9.6%Sector median 12.3%
OPM12.1%Sector median 14.0%
Debt / equity0.04xSector median 0.16x
EV/EBITDA10.5xSector median 18.6x
Interest cover46.4x
Current ratio3.40x
Sales growth 3y+1.1%Sector median +9.6%
Profit growth 3y-8.3%Sector median +13.3%
PEG–
Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 185 companies in Pharmaceuticals (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹4 cr vs borrowings ₹6 cr (FY26): borrowings are higher by ₹2 cr.
- Operating profit covered interest 46.4x in the last 12 months.
- Other income was 34% of net profit in the last 12 months.
- Dividend paid in 1 of the last 5 financial years.
- Price ₹102.95 on 2026-10-26: -33.3% from the 52-week high, +19.6% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹251.00 · low ₹95.65
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | 28 | 24 | 25 | 27 | 31 | 25 |
| EBITDA | 5 | 4 | 4 | 4 | 2 | 3 |
| OPM % | 16.8% | 15.9% | 13.9% | 14.1% | 7.8% | 13.5% |
| Other income | 0 | 1 | 1 | 1 | 1 | 1 |
| Net profit | 3 | 3 | 3 | 4 | 2 | 2 |
| EPS (₹) | 4.82 | 2.16 | 3.96 | 2.79 | 1.29 | 1.76 |
| Revenue YoY | +9.5% | +4.7% | ||||
| Profit YoY | -46.4% | -18.9% |
Standalone figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 69 | 103 | 105 | 107 | 107 | 108 |
| EBITDA | 13 | 20 | 19 | 18 | 14 | 13 |
| Net profit | 8 | 14 | 14 | 14 | 11 | 10 |
| EPS (₹) | 8.33 | 12.78 | 11.88 | 20.94 | 8.22 | 9.80 |
| Revenue growth | +49.5% | +2.0% | +1.9% | -0.4% | – | |
| Profit growth | +68.3% | +0.3% | -2.3% | -21.5% | – | |
| Dividend / share (₹) | – | – | – | – | 2.40 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +1.2% | – | – |
| Net profit | -8.4% | – | – |
| EPS | -13.7% | – | – |
| Share price | – | -32.7% (2y) | -25.7% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 134 | 141 |
| Borrowings | 5 | 6 |
| Cash & equivalents | 4 | 4 |
| Total assets | 163 | 172 |
| Fixed assets | 18 | 20 |
| Capital work in progress | 15 | 17 |
| Investments | 0 | 0 |
| Receivables | 35 | 39 |
| Inventory | 46 | 45 |
| Payables | 16 | 18 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | 4 | 10 |
| Cash from investing | -16 | -7 |
| Cash from financing | -5 | -4 |
| Capex | 16 | 7 |
| Free cash flow | -12 | 3 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | 10.3% | 7.7% |
| ROCE % | 13.3% | 10.0% |
| Debtor days | 119 | 134 |
| Inventory days | 246 | 230 |
| Payable days | 88 | 90 |
| Cash conversion cycle (days) | 277 | 274 |
| Working capital days | 219 | 216 |
Peers in Pharmaceuticals
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| SUNPHARMA | ₹4,17,478 cr | 34.5x | 5.0x | 15.5% | 18.7% | 28.6% | +10.0% | 0.94% |
| DIVISLAB | ₹2,39,825 cr | 82.1x | 14.3x | 18.4% | 23.0% | 34.7% | +10.8% | 0.34% |
| TORNTPHARM | ₹1,53,999 cr | 72.7x | 18.4x | 27.3% | 15.1% | 32.3% | +13.3% | 0.84% |
| ZYDUSLIFE | ₹1,15,808 cr | 25.9x | 4.3x | 17.7% | 16.8% | 27.2% | +16.4% | 0.95% |
| LAURUSLABS | ₹1,11,232 cr | 101.6x | 21.0x | 22.4% | 20.8% | 28.0% | +4.1% | 0.08% |
| CIPLA | ₹1,09,464 cr | 32.5x | 3.2x | 10.3% | 13.2% | 17.7% | +7.4% | 1.18% |
| DRREDDY | ₹1,09,460 cr | 33.9x | 2.9x | 9.0% | 10.1% | 15.5% | +11.0% | 0.61% |
| MANKIND | ₹95,486 cr | 46.7x | 5.9x | 13.4% | 13.8% | 25.1% | +17.7% | 0.04% |
| AUROPHARMA | ₹91,489 cr | 24.9x | 2.4x | 10.5% | 12.8% | 20.0% | +10.6% | 0.26% |
| PANCHSHEEL | ₹136 cr | 10.5x | 1.0x | 7.5% | 9.6% | 12.1% | +1.1% | 3.11% |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-08-21 | Dividend | Interim Dividend Rs 0.8 |
| 2026-06-12 | Dividend | Final Dividend Rs 0.8 |
| 2026-02-20 | Dividend | Interim Dividend Rs 0.8 |
| 2025-11-21 | Dividend | Interim Dividend Rs 0.8 |
| 2025-08-22 | Dividend | Interim Dividend Rs 0.8 |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Healthcare |
| Industry | Pharmaceuticals |
| Sub-industry | Pharmaceuticals |
| Symbol | PANCHSHEEL |
| BSE code | 531726 |
| ISIN | INE316G01019 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.